| Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys A Recasens, B Dehay, J Bové, I Carballo‐Carbajal, S Dovero, ... Annals of neurology 75 (3), 351-362, 2014 | 695 | 2014 |
| Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein SM Fleming, J Salcedo, PO Fernagut, E Rockenstein, E Masliah, ... Journal of Neuroscience 24 (42), 9434-9440, 2004 | 566 | 2004 |
| Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ... Progress in neurobiology 132, 96-168, 2015 | 499 | 2015 |
| Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders V Voon, PO Fernagut, J Wickens, C Baunez, M Rodriguez, N Pavon, ... The Lancet Neurology 8 (12), 1140-1149, 2009 | 434 | 2009 |
| Direct regulation of adult brain function by the male-specific factor SRY P Dewing, CWK Chiang, K Sinchak, H Sim, PO Fernagut, S Kelly, ... Current Biology 16 (4), 415-420, 2006 | 412 | 2006 |
| Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update V Voon, TC Napier, MJ Frank, V Sgambato-Faure, AA Grace, ... The Lancet Neurology 16 (3), 238-250, 2017 | 321 | 2017 |
| Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone SM Fleming, C Zhu, PO Fernagut, A Mehta, CD DiCarlo, RL Seaman, ... Experimental neurology 187 (2), 418-429, 2004 | 279 | 2004 |
| Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification? F Bassil, PO Fernagut, E Bezard, WG Meissner Progress in neurobiology 118, 1-18, 2014 | 242 | 2014 |
| Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α‐synuclein over‐expression PO Fernagut, CB Hutson, SM Fleming, NA Tetreaut, J Salcedo, E Masliah, ... Synapse 61 (12), 991-1001, 2007 | 240 | 2007 |
| Alpha-synuclein and transgenic mouse models PO Fernagut, MF Chesselet Neurobiology of disease 17 (2), 123-130, 2004 | 240 | 2004 |
| A simple method to measure stride length as an index of nigrostriatal dysfunction in mice PO Fernagut, E Diguet, B Labattu, F Tison Journal of neuroscience methods 113 (2), 123-130, 2002 | 236 | 2002 |
| Genetic mouse models of parkinsonism: strengths and limitations SM Fleming, PO Fernagut, MF Chesselet NeuroRx 2 (3), 495-503, 2005 | 214 | 2005 |
| Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease E Diguet, PO Fernagut, X Wei, Y Du, R Rouland, C Gross, E Bezard, ... European Journal of Neuroscience 19 (12), 3266-3276, 2004 | 202 | 2004 |
| Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation PO Fernagut, E Diguet, N Stefanova, M Biran, GK Wenning, P Canioni, ... Neuroscience 114 (4), 1005-1017, 2002 | 185 | 2002 |
| Dopamine and addiction: what have we learned from 40 years of research M Solinas, P Belujon, PO Fernagut, M Jaber, N Thiriet Journal of Neural Transmission 126, 481-516, 2019 | 140 | 2019 |
| Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression M Bourdenx, S Dovero, M Engeln, S Bido, MF Bastide, N Dutheil, ... Acta neuropathologica communications 3, 1-15, 2015 | 123 | 2015 |
| Protein aggregation in the aging retina F Leger, PO Fernagut, MH Canron, S Léoni, C Vital, F Tison, E Bezard, ... Journal of Neuropathology & Experimental Neurology 70 (1), 63-68, 2011 | 115 | 2011 |
| Variable effects of chronic subcutaneous administration of rotenone on striatal histology C Zhu, P Vourc'h, PO Fernagut, SM Fleming, S Lacan, CD Dicarlo, ... Journal of Comparative Neurology 478 (4), 418-426, 2004 | 110 | 2004 |
| Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice PO Fernagut, S Chalon, E Diguet, D Guilloteau, F Tison, M Jaber Neuroscience 116 (4), 1123-1130, 2003 | 108 | 2003 |
| Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy F Bassil, PO Fernagut, E Bezard, A Pruvost, T Leste-Lasserre, QQ Hoang, ... Proceedings of the National Academy of Sciences 113 (34), 9593-9598, 2016 | 106 | 2016 |
